J Cervenka

1.3k total citations
27 papers, 1.2k citations indexed

About

J Cervenka is a scholar working on Cardiology and Cardiovascular Medicine, Cell Biology and Epidemiology. According to data from OpenAlex, J Cervenka has authored 27 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 7 papers in Cell Biology and 5 papers in Epidemiology. Recurrent topics in J Cervenka's work include Cellular transport and secretion (7 papers), Blood Pressure and Hypertension Studies (7 papers) and Neuroendocrine Tumor Research Advances (5 papers). J Cervenka is often cited by papers focused on Cellular transport and secretion (7 papers), Blood Pressure and Hypertension Studies (7 papers) and Neuroendocrine Tumor Research Advances (5 papers). J Cervenka collaborates with scholars based in United States, Mexico and Germany. J Cervenka's co-authors include Robert J. Parmer, Daniel T. O’Connor, Richard A. Stone, M A Takiyyuddin, Juan A. Barbosa, Mala T. Kailasam, Brian P. Kennedy, Michael G. Ziegler, M.R. Pandian and Hartmut P.H. Neumann and has published in prestigious journals such as Circulation, The Journal of Clinical Endocrinology & Metabolism and Kidney International.

In The Last Decade

J Cervenka

27 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Cervenka United States 17 391 347 213 195 170 27 1.2k
Simon J. Potocnik Australia 17 481 1.2× 309 0.9× 132 0.6× 114 0.6× 39 0.2× 36 1.1k
Takeshi Katsuragi Japan 24 899 2.3× 383 1.1× 458 2.2× 50 0.3× 94 0.6× 108 1.9k
André G. Douen Canada 17 835 2.1× 120 0.3× 91 0.4× 362 1.9× 189 1.1× 26 1.5k
Casper Skjærbæk Denmark 17 374 1.0× 219 0.6× 108 0.5× 53 0.3× 130 0.8× 38 1.4k
Josep Oriola Spain 20 854 2.2× 186 0.5× 89 0.4× 75 0.4× 302 1.8× 77 1.8k
Angelo Margutti Italy 19 234 0.6× 236 0.7× 250 1.2× 20 0.1× 249 1.5× 59 1.1k
Kevin M. Lawrence United Kingdom 23 601 1.5× 132 0.4× 257 1.2× 55 0.3× 60 0.4× 47 1.6k
Marta Barontini Argentina 23 305 0.8× 149 0.4× 140 0.7× 26 0.1× 146 0.9× 73 1.4k
Margaret Peterson United States 15 290 0.7× 189 0.5× 66 0.3× 48 0.2× 79 0.5× 28 1.4k
Bruce Culver United States 17 323 0.8× 159 0.5× 118 0.6× 45 0.2× 76 0.4× 28 1.0k

Countries citing papers authored by J Cervenka

Since Specialization
Citations

This map shows the geographic impact of J Cervenka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Cervenka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Cervenka more than expected).

Fields of papers citing papers by J Cervenka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Cervenka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Cervenka. The network helps show where J Cervenka may publish in the future.

Co-authorship network of co-authors of J Cervenka

This figure shows the co-authorship network connecting the top 25 collaborators of J Cervenka. A scholar is included among the top collaborators of J Cervenka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Cervenka. J Cervenka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kailasam, Mala T., et al.. (1998). Racial differences in renal kallikrein excretion: Effect of the ovulatory cycle. Kidney International. 54(5). 1652–1658. 16 indexed citations
2.
Takiyyuddin, M A, Robert J. Parmer, Mala T. Kailasam, et al.. (1995). Chromogranin A in Human Hypertension. Hypertension. 26(1). 213–220. 92 indexed citations
3.
Kailasam, Mala T., Robert J. Parmer, J Cervenka, et al.. (1995). Divergent Effects of Dihydropyridine and Phenylalkylamine Calcium Channel Antagonist Classes on Autonomic Function in Human Hypertension. Hypertension. 26(1). 143–149. 64 indexed citations
4.
Takiyyuddin, M A, Marvin R. Brown, Thai Dinh, et al.. (1994). Sympatho‐adrenal secretion in humans: factors governing catecholamine and storage vesicle peptide co‐release *. Journal of Autonomic Pharmacology. 14(3). 187–200. 53 indexed citations
5.
Kailasam, Mala T., et al.. (1994). Effects of an oral prostaglandin E1 agonist on blood pressure and its determinants in essential hypertension.. PubMed. 8(7). 515–20. 8 indexed citations
6.
O’Connor, Daniel T., J Cervenka, Richard A. Stone, et al.. (1993). Chromogranin a immunoreactivity in human cerebrospinal fluid: Properties, relationship to noradrenergic neuronal activity, and variation in neurologic disease. Neuroscience. 56(4). 999–1007. 21 indexed citations
7.
Parmer, Robert J., J Cervenka, & Richard A. Stone. (1992). Baroreflex sensitivity and heredity in essential hypertension.. Circulation. 85(2). 497–503. 132 indexed citations
8.
Takiyyuddin, M A, Hartmut P.H. Neumann, J Cervenka, et al.. (1991). Ultradian variations of chromogranin A in humans. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 261(4). R939–R944. 26 indexed citations
9.
Takiyyuddin, M A, Alain Baron, J Cervenka, et al.. (1991). Suppression of Chromogranin-A Release from Neuroendocrine Sources in Man: Pharmacological Studies*. The Journal of Clinical Endocrinology & Metabolism. 72(3). 616–622. 34 indexed citations
10.
Takiyyuddin, M A, J Cervenka, P. A. Sullivan, et al.. (1990). Is physiologic sympathoadrenal catecholamine release exocytotic in humans?. Circulation. 81(1). 185–195. 93 indexed citations
11.
Takiyyuddin, M A, J Cervenka, M.R. Pandian, et al.. (1990). Neuroendocrine Sources of Chromogranin-A in Normal Man: Clues from Selective Stimulation of Endocrine Glands*. The Journal of Clinical Endocrinology & Metabolism. 71(2). 360–369. 46 indexed citations
12.
Takiyyuddin, M A, J Cervenka, Ruth Hsiao, et al.. (1990). Chromogranin A. Storage and release in hypertension.. Hypertension. 15(3). 237–246. 83 indexed citations
13.
O’Connor, Daniel T., M A Takiyyuddin, J Cervenka, et al.. (1990). Circulating chromogranin A as a diagnostic tool in clinical chemistry.. PubMed. 38. 27–33. 6 indexed citations
14.
15.
Takiyyuddin, M A, J Cervenka, Thai Dinh, Joseph L. Witztum, & Daniel T. O’Connor. (1989). Selective alpha-blockade versus angiotensin-converting enzyme inhibition as initial antihypertensive therapy. The American Journal of Medicine. 86(1). 32–35. 7 indexed citations
16.
17.
CONNOR, D. T., et al.. (1984). Comparative Effects of Antihypertensive Therapy with Guanabenz and Propranolol on Renal Vascular Resistance and Left Ventricular Mass. Journal of Cardiovascular Pharmacology. 6(Supplement 5). 5757–5757. 4 indexed citations
18.
Cervenka, J, et al.. (1984). Contrasting renal haemodynamic responses to the angiotensin converting enzyme inhibitor enalapril and the beta-adrenergic antagonist metoprolol in essential hypertension.. PubMed. 2(2). S89–92. 13 indexed citations
19.
CONNOR, D. T., et al.. (1982). Guanabenz selectively reduces renal vascular resistance in essential hypertension. Kidney International. 21(1). 191. 2 indexed citations
20.
Warren, Sanford E., et al.. (1979). Mechanism of action of hydro chlorothiazide and guanabenz. Kidney International. 16(6). 924. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simon J. Potocnik Breakdown of academic impact, for papers by Takeshi Katsuragi Breakdown of academic impact, for papers by André G. Douen Breakdown of academic impact, for papers by Casper Skjærbæk Breakdown of academic impact, for papers by Josep Oriola Breakdown of academic impact, for papers by Angelo Margutti Breakdown of academic impact, for papers by Kevin M. Lawrence Breakdown of academic impact, for papers by Marta Barontini Breakdown of academic impact, for papers by Margaret Peterson Breakdown of academic impact, for papers by Bruce Culver
Rankless by CCL
2026